Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trialsHeidar Sharafi, Didier Jutras‐Aswad, Bernard Le Foll et al.|Addiction|2023Cited by 30
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trialsHamzah Bakouni, Didier Jutras‐Aswad, Heidar Sharafi et al.|Drug and Alcohol Dependence|2023Cited by 22
Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA studyLaurent Elkrief, Louis-Christophe Juteau, Gabriel Bastien et al.|Journal of Substance Use and Addiction Treatment|2023Cited by 9
A protocol for high-dose lisdexamfetamine and contingency management, alone or in combination, for the treatment of methamphetamine use disorder: The ASCME studyPaxton Bach, Didier Jutras-Aswad, Bernard Le Foll et al.|Contemporary Clinical Trials|2025Cited by 0